Premium
Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves’ ophthalmopathy
Author(s) -
Syed A. A.,
Simmonds M. J.,
Brand O. J.,
Franklyn J. A.,
Gough S. C. L.,
Heward J. M.
Publication year - 2007
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2007.02942.x
Subject(s) - ptpn22 , single nucleotide polymorphism , genotype , protein tyrosine phosphatase , snp , endocrinology , medicine , kinase , phosphatase , receptor , proto oncogene tyrosine protein kinase src , biology , cancer research , genetics , gene , phosphorylation
Summary Objective Protein tyrosine phosphatases (PTPs), such as PTPN22, are important regulators of signal transduction from the T cell receptor and have been associated with autoimmunity. PTPN12 interacts with the same T cell activation accessory molecules, Grb2 and Csk kinase, as the Graves’ disease (GD) associated PTPN22 encoded lymphoid tyrosine phosphatase (LYP) molecule and also plays a key role in T cell receptor signalling, leading to the hypothesis that it too may be involved in GD susceptibility. Design PTPN12 was tested for association in a large well‐characterized UK Caucasian case control cohort using seven tagging single nucleotide polymorphisms (SNPs). Patients A total of 1058 GD patients and 864 controls. Measurements Tests for association with the disease. Results Despite adequate statistical power to detect an effect if present, none of the seven tag SNPs were associated with GD ( P = 0·925–0·089). Three SNPs (rs1468682, rs4729535 and rs17467232), however, demonstrated association with the presence of ophthalmopathy NOSPECS classes 2–4 ( P = 0·039–0·004). Four SNPs (rs1468682, rs4729535, rs17155601 and rs17467232) revealed evidence of interaction with the previously associated thyrotropin hormone receptor ( TSHR ) rs2268458 SNP ( P = 0·035–0·002). Conclusions No association was detected between individual PTPN12 tag SNPs and GD but preliminary evidence suggests PTPN12 confers an increased risk of mild/moderate ophthalmopathy (NOSPECS classes 2–4) and that PTPN12 interacts with the TSHR . Replication of these preliminary results is now required in larger independent datasets to validate these findings.